Serbia donates Pfizer COVID-19 vaccines to North Macedonia

Serbia has donated a first batch of 8,000 doses of Pfizer COVID-19 vaccines to North Macedonia, which is yet to deliver its first jabs

Via AP news wire
Sunday 14 February 2021 11:39
Virus Outbreak North Macedonia Serbia Vaccines
Virus Outbreak North Macedonia Serbia Vaccines

Serbia on Sunday donated a first batch of 8,000 doses of Pfizer COVID-19 vaccines to North Macedonia, which is yet to deliver its first jabs.

Serbian President Aleksandar Vucic and North Macedonian Prime Minister Zoran Zaev attended a border checkpoint handover ceremony of the shipment, praising friendship between the two neighboring Balkan states.

Serbia, a country of 7 million, has so far vaccinated some 600,000 people, mainly with the Chinese Sinopharm vaccine and Russian Sputnik V, and to a lesser extent with the Pfizer jab. The country has been one of the most successful in Europe in terms of how fast it has rolled out the vaccine among its population.

By contrast, North Macedonia, like most of other Western Balkan countries, has not yet secured a single dose of the coronavirus vaccine for its population of 2.1 million. Many of the states in the region are reconsidering their strategy of waiting for Western-supplied shots and are mulling the purchase of the Chinese and Russian ones.

“A friend in need is a friend indeed,” Vucic said, while Zaev praised him for showing the “real solidarity in practice."

The vaccine handover had to be postponed last week because Pfizer and its German partner BioNTech had demanded “additional documentation” from Serbia on the re-export of its shots, Vucic said.

Vucic’s opponents in Serbia have called his vaccine donation to North Macedonia another of his populist political moves meant to portray him as the main regional leader. They say many in Serbia are still waiting in line to get inoculated with their first choice Pfizer shots.

Earlier this week, North Macedonian authorities signed an agreement to procure 200,000 doses of the Chinese Sinopharm vaccine, with which they hope to launch their vaccination program later this month.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in